COVA Acquisition Corp. (NASDAQ:COVA) announced this morning that its shareholders have approved and closed its business combination with global mobility tech company ECARX Holdings during a special meeting held on Wednesday, December 14.
The SPAC disclosed in an 8-K last week that 29,379,643 shares were redeemed in connection with the meeting, removing 97.93% of the trust.
The parties were able to close the deal yesterday, December 20. The combined company will retain the ECARX name and its shares and warrants are expected to commence trading on NASDAQ under the symbols “ECX” and “ECXWW,” respectively, today.
COVA initially announced the $3.5 billion combination with ECARX on May 26, 2022. Hubai, China-based ECARX develops hardware and software solutions for the development of connected, automated and electrified mobility, which it supplies to the global automotive industry.
ECARX recorded $415 million in revenue in 2021 and its technology has been integrated into more than 3.7 million cars serving 12 OEM brands across Asia and Europe. Going forward, ECARX expects to continue delivering growth as it expands the number of cars served and increases the revenue per car through product rollouts and partnerships.
Advisors
- UBS AG Hong Kong Branch acted as joint financial advisor to ECARX.
- Morgan Stanley Asia Limited acted as joint financial advisor to ECARX.
- Skadden, Arps, Slate, Meagher & Flom acted as international legal counsel to ECARX.
- Cantor Fitzgerald & Co. acted as capital markets advisor to COVA Acquisition Corp.
- Orrick, Herrington & Sutcliffe LLP acted as its legal counsel.
Terms Tracker for the Week Ending March 31, 2023 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. Filings continue to remain quiet, but SPACs did manage to price two more IPOs this week with TMT Acquisition Corp (Nasdaq: TMTCU) and Trailblazer Merger...
Hudson Acquisition I Corp. (NASDAQ:HUDA) announced that it has signed a non-binding letter of intent (LOI) to combine with a pre-clinical-stage biotechnology company. The SPAC did not provide many details on the unnamed target, but disclosed that the biotech company is focused on developing intranasal preventives for major disease-causing respiratory viruses. As a condition to the target...
Heading into April, SPACs are to see eight sponsors and 11 de-SPAC’d companies freed from lock-ups and ready to trade. Most of these lock-up expirations are loaded into the final week of the month, but those hitting this milestone already next week include some of the more interesting transactions of the crop. In particular, MoonLake...
Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. Latest SPAC News: Shares of Digital World jump after Trump’s indictment, and pair of Delaware Chancery court decisions deny motions to dismiss SPAC shareholder’s fiduciary breach claims Trump-Tied SPAC’s Shares Jump After Historic New York Charge The...
Ares Acquisition Corporation II (NYSE:AACT) filed its S-1 yesterday afternoon for a $400 million IPO, marking the second SPAC to file for an IPO in March and the largest since December 20, 2021, when Gores Holdings X Inc. filed for a $725 million SPAC. Ares II intends to focus its search on an established target...